Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair for Uncontrolled Lower Respiratory Symptoms in WTC Survivors
NCT02024204Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2014
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of fluticasone propionate and salmeterol (2 arms), sponsored by NYU Langone Health. Primary endpoints: Forced Oscillation Technique Measures at 12 weeks and Spirometry Measures at 12 weeks. Started Apr 2014; status: completed.
02
Drugs
fluticasone propionatesalmeterol
Beyond the preview
Go deeper on NCT02024204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024204.